Fortrea
Elissa Hahn is an experienced Executive Assistant with a strong background in supporting top executives in various organizations. Currently serving as Executive Assistant to the Chairman and CEO at Fortrea since January 2023, Elissa previously held the same role for the Chief Executive Officer at Labcorp Drug Development from December 2019 to June 2023. Elissa's career also includes positions as an Executive Assistant PM CoE at Covance and an Administrative Coordinator at QuintilesIMS, where responsibilities encompassed managing safety programs, project timelines, global travel initiatives, and providing administrative support across multiple departments. Elissa holds a BA in Communication Studies from the University of North Carolina Wilmington.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.